2023 annual financial data
Traws Pharma 2023 Operating margin
Traws Pharma 2023 operating margin with verified reported values.
Direct answer
Operating margin was -8,981.42%.
Operating income was -20,298,000 USD and net income was -18,948,000 USD.
Operating cash flow was -17,932,000 USD.
Get free Traws Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 226,000 USD
- Operating income
- -20,298,000 USD
- Net income
- -18,948,000 USD
- Operating cash flow
- -17,932,000 USD